Lilly Focuses On ‘Traditional’ Approval For Donanemab, Increased Mounjaro Production

 
• By Joseph Haas
Fourth quarter
Lilly intends to increase production capacity for Mounjaro ahead of obesity approval • Source: Shutterstock

More from Earnings

More from Business